Upgrade to SI Premium - Free Trial

Form SCHEDULE 13D Apollomics Inc. Filed by: Chen Yi-Kuei

April 8, 2026 7:01 PM





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Rows 8, 10 and 11 include (i) 101,248 Shares held by Maxpro Investment Co., Ltd. ("Maxpro"), (ii) 3,823 Shares issuable upon exercise of warrants held by Maxpro that are exercisable within 60 days of the date of this Schedule 13D, and (iii) 10,000 restricted stock units representing the right to receive Shares held directly by Mr. Chen, consisting of 5,000 RSUs that vested on February 17, 2026 and 5,000 RSUs scheduled to vest on May 17, 2026 (which is within 60 days of the date of this Schedule 13D). The warrants and RSUs are included pursuant to Rule 13d-3(d)(1) as rights to acquire Shares within 60 days. RSUs do not provide shareholder voting rights prior to settlement/issuance of Shares.


SCHEDULE 13D


Yi-Kuei Chen
Signature:/s/ Yi-Kuei Chen
Name/Title:Yi-Kuei Chen
Date:04/08/2026

Categories

SEC Filings